Skip to content

What is the cut off point for sarcopenia? Diagnostic Criteria Explained

2 min read

Experts estimate that up to 50% of people over 80 are affected by sarcopenia, a condition characterized by progressive muscle loss. Understanding what is the cut off point for sarcopenia is crucial for early diagnosis and intervention to prevent mobility issues and falls.

Quick Summary

The cut-off points for sarcopenia vary depending on the diagnostic criteria used by different international and regional working groups. A diagnosis is based on assessing low muscle strength, low muscle mass, and reduced physical performance.

Key Points

  • No Single Cut-off: Diagnostic thresholds vary and are determined by international and regional working groups, combining multiple criteria.

  • EWGSOP2 is Key: The most influential criteria prioritize low muscle strength (grip strength <27kg men, <16kg women) as the primary indicator.

  • Diagnosis is Three-Part: Can involve low muscle strength, low muscle mass, and low physical performance.

  • Staging Determines Severity: Condition is staged as probable, confirmed, or severe based on criteria met.

  • Measurement Matters: Tools like handgrip dynamometers and BIA are widely used; DXA and MRI are more accurate but expensive.

  • Regional Differences Exist: Cut-off points can differ across populations.

In This Article

Sarcopenia: Defining the Diagnostic Landscape

Sarcopenia is a progressive loss of skeletal muscle mass and strength, significantly impacting quality of life and independence, especially in older adults. Defining what is the cut off point for sarcopenia is key for diagnosis, but there isn't a single universal threshold. Diagnostic criteria have evolved, with guidelines from groups like the European Working Group on Sarcopenia in Older People (EWGSOP) and its updated version, EWGSOP2, being widely used.

The EWGSOP2 Diagnostic Criteria (2018)

The EWGSOP2 guidelines prioritize low muscle strength as the primary indicator of probable sarcopenia. The diagnostic process is sequential:

  • Probable Sarcopenia: Indicated by low muscle strength (grip strength < 27 kg for men, < 16 kg for women; chair stand test > 15 seconds for five rises).
  • Confirmation of Sarcopenia: Low strength plus low muscle quantity or quality (ASM mass by DXA < 20 kg for men, < 15 kg for women; ASM/height² by DXA < 7.0 kg/m² for men, < 5.5 kg/m² for women).
  • Severe Sarcopenia: Low muscle strength, low muscle mass, and low physical performance are all present.

The Role of Physical Performance in Diagnosis

Physical performance tests assess sarcopenia severity. Key cut-offs include a gait speed of ≤ 0.8 m/s, SPPB score ≤ 8, or TUG test ≥ 20 seconds.

Global Variations in Sarcopenia Cut-offs

Cut-off points vary across working groups due to differences in body size and demographics. The Asian Working Group for Sarcopenia (AWGS) and the FNIH Sarcopenia Project provide examples of regional and alternative criteria.

Measurement Techniques and Their Accuracy

The tools used to measure sarcopenia parameters vary. The table below compares common methods:

Method Primary Measure Cost Accuracy Clinical Setting Suitability
Dual-energy X-ray Absorptiometry (DXA) Appendicular Lean Mass (ALM) Moderate to High High Good (Standard for routine assessment)
Bioelectrical Impedance Analysis (BIA) Appendicular Skeletal Muscle Mass (ASM) Low Moderate (Affected by hydration) Excellent (Portable, rapid)
Handgrip Dynamometry Muscle Strength Low Good Excellent (Simple, quick)
Gait Speed Test Physical Performance Low Good Excellent (Simple, predictive)
Computed Tomography (CT) & MRI Muscle Mass/Quality High Very High (Gold Standard) Limited (High cost, research focus)

The Staging of Sarcopenia

Diagnosis allows for staging:

  1. Presarcopenia: Low muscle mass without reduced strength or performance.
  2. Sarcopenia: Low muscle mass plus either low strength or low performance.
  3. Severe Sarcopenia: Low muscle mass, low strength, and low performance.

Conclusion

There is no single cut off point for sarcopenia, but criteria from groups like EWGSOP2 are widely used. Diagnosis involves assessing muscle strength, mass, and physical performance. Regional differences exist. For more information, refer to {Link: NIH website https://pmc.ncbi.nlm.nih.gov/articles/PMC8658070/}.

Frequently Asked Questions

EWGSOP2 identifies low muscle strength (low handgrip strength or poor chair stand test) as primary. Confirmation requires measuring low muscle mass.

Thresholds vary across groups due to differences in measurement techniques, demographics, body size, and genetics.

Methods include DXA (common for clinical/research), BIA, CT, and MRI.

EWGSOP2 considers a usual gait speed of ≤ 0.8 m/s over 4 meters as indicating poor physical performance.

Severe sarcopenia involves low muscle mass, low strength, AND low physical performance. Sarcopenia requires low mass plus either low strength or low performance.

Yes, tools like the SARC-F questionnaire can screen for risk. A score of 4+ is predictive.

Normal is above EWGSOP2 cut-offs (<27 kg men, <16 kg women). Scores at or below indicate probable sarcopenia.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.